Physician

Mohsen Arani, MD

According to 2025 Medicare claims, Mohsen Arani, MD (NPI: 1821097072) practices hematology/oncology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is MILLENNIUM PHYSICIANS ASSOCIATION, PLLC (NPI: 1255397733; TIN: 760528826) and primary practice location at 77380-3485. Arani is affiliated with the Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Arani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 700 traditional Medicare patients, billed 378,691 HCPCS/CPT codes, and received $4,260,053 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,662 prescription claims across 442 beneficiaries totaling $6,598,992 in drug costs, led by Revlimid (Lenalidomide). DME data shows 51 claims. Open Payments data shows 367 records totaling $45,958. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $5,917,863 to $4,260,053. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,920,440 to $6,598,992. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	844	737,501	$5,917,863
2016	868	691,441	$6,009,988
2017	868	702,100	$6,550,226
2018	836	564,792	$7,091,678
2019	780	612,522	$7,924,218
2020	720	576,898	$6,554,958
2021	670	352,790	$4,315,120
2022	632	389,320	$4,478,451
2023	640	396,455	$4,014,254
2024	700	378,691	$4,260,053

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	358	2,538	$1,920,440
2016	378	2,679	$2,110,259
2017	392	2,696	$2,239,576
2018	374	2,872	$3,251,515
2019	371	2,904	$4,271,546
2020	363	2,603	$4,231,183
2021	366	2,386	$4,270,261
2022	377	2,440	$3,966,123
2023	388	2,497	$4,795,967
2024	442	2,662	$6,598,992

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	51	$16,739
2017	N/R	11	$7,167
2018	N/R	N/R	N/R
2019	N/R	12	$727
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	51	$1,503

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	82	82	$165
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	410	911	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	324	449	$64
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	92	302	$47
96372	Injection of drug or substance under skin or into muscle	82	436	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	51	1,316	$947,607
Erleada	Apalutamide	53	1,590	$788,992
Lenalidomide	Lenalidomide	37	980	$553,198
Calquence	Acalabrutinib Maleate	33	990	$478,257
Jakafi	Ruxolitinib Phosphate	25	750	$423,660

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	23	$1,051
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$301
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	362	$30,214	OnMark, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$15,744	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohsen Arani, MD?

Tedicare shows public-source Medicare data for Mohsen Arani, MD (NPI 1821097072), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohsen Arani, MD have ACO affiliation data?

Mohsen Arani, MD is shown with ACO affiliation data for Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mohsen Arani, MD?

Mohsen Arani, MD is linked to MILLENNIUM PHYSICIANS ASSOCIATION, PLLC (billing NPI 1255397733) in the available physician profile data.

Does Mohsen Arani, MD have Open Payments data?

Mohsen Arani, MD has 367 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.